Here are the 424B prospectus supplements from InnovAge Holding Corp. (INNV) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow INNV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INNV filings page.
InnovAge Holding Corp. registered 10,000,000 shares of common stock for resale by selling security holder TCO Group Holdings, L.P.; InnovAge will receive no proceeds from these sales. The selling holder has granted the underwriters an option, exercisable within 30 days of the prospectus supplement, to purchase up to 1,500,000 additional shares from it. At a public offering price of $9.25 per share, the base offering totals $92.5 million. After $4.625 million in underwriting discounts and commissions, proceeds before expenses to the selling holder are $87.875 million.
InnovAge estimates its offering expenses at approximately $1.0 million, excluding underwriting discounts and commissions, and says it will pay certain expenses incurred by the selling holder. InnovAge had 136,451,425 shares outstanding as of September 21, 2026. After the base offering, the Principal Shareholders will control approximately 75.2% of voting power; the figure is 74.1% if the option is exercised in full. InnovAge says it does not anticipate paying cash dividends in the foreseeable future.
InnovAge Holding Corp. (INNV) has filed a preliminary prospectus supplement for a secondary offering of 10,000,000 existing shares of common stock to be sold by selling security holder TCO Group Holdings, L.P. The underwriters have a 30‑day option to purchase up to 1,500,000 additional shares from the same holder. InnovAge will not receive any proceeds from these sales; all net proceeds go to the selling security holder.
The company’s common stock trades on Nasdaq under the symbol INNV, with a last reported price of $10.60 per share on September 21, 2026. Shares outstanding were 136,451,425 as of that date. As of June 30, 2026, InnovAge served approximately 8,230 PACE participants across 20 PACE centers in six states under its fully capitated, value‑based care model for frail, largely dual‑eligible seniors. After this offering, Principal Shareholders are expected to retain about 75.2% of voting power (74.1% if the option is fully exercised), maintaining their ability to control shareholder votes and board composition.